Coquitlam, Canada

Nick Cheng


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Nick Cheng in Therapeutic Applications

Introduction

Nick Cheng is an accomplished inventor based in Coquitlam, Canada. He has made significant contributions to the field of therapeutic drugs, particularly in the treatment of inflammatory and autoimmune diseases. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Nick Cheng holds a patent for IL-8 receptor ligands, which are drugs designed for inflammatory and autoimmune diseases. The invention provides therapeutic and biological uses of chemokine-receptor-binding compounds, including chemokine receptor ligands such as agonists or antagonists. Specifically, the invention focuses on benzopyrone derivatives and their applications in treating disease states mediated by chemokines. The relevant chemokine in this context is interleukin-8 (IL-8), with corresponding chemokine receptors being CXCR-1 and/or CXCR-2. Additionally, the invention includes pharmaceutical compositions and therapeutic methods, highlighting the use of [7-[benzopyrone-5′(3′-amino)-thiazole]-phenylalanine-benzyl ester] in treatment.

Career Highlights

Throughout his career, Nick Cheng has been associated with Chemokine Therapeutic Corporation, where he has focused on advancing therapeutic solutions. His work has garnered attention for its potential impact on treating diseases that involve chemokine signaling pathways. With a patent portfolio that includes 1 patent, Cheng continues to push the boundaries of medical innovation.

Collaborations

Nick Cheng has collaborated with notable colleagues, including Geeta Saxena and Christopher R Tudan. These partnerships have contributed to the development and refinement of his innovative therapeutic approaches.

Conclusion

Nick Cheng's contributions to the field of therapeutic drugs exemplify the importance of innovation in addressing complex health challenges. His work on IL-8 receptor ligands showcases the potential for new treatments in inflammatory and autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…